1.
Transaction | General Journal | Debit | Credit |
a. | No journal entry required | ||
b. | Cash | 7700000 | |
Notes payable | 7700000 | ||
(To record borrowing against note) | |||
c. | Cash | 2700 | |
Liability for refundable deposits | 2700 | ||
(To record refundable deposits received) | |||
d. | Cash/Accounts receivable | 4831600 | |
Sales tax payable (70% x $4700000 x 4%) | 131600 | ||
Sales revenue | 4700000 | ||
(To record sales) | |||
e. | Interest expense ($7700000 x 12% x 3/12) | 231000 | |
Interest payable | 231000 | ||
(To record interest accrued on note) |
2.
Balance Sheet (partial) | |
At December 31, 2021 | |
Current liabilities: | |
Notes payable | 7700000 |
Liability for refundable deposits | 2700 |
Sales tax payable | 131600 |
Interest payable | 231000 |
Total current liabilities | 8065300 |
3.
Transaction | General Journal | Debit | Credit |
a. | Notes payable | 7700000 | |
Interest payable | 231000 | ||
Interest expense ($7700000 x 12% x 2/12) | 154000 | ||
Cash | 8085000 | ||
(To record the payment of note) | |||
b. | Liability for refundable deposits | 1350 | |
Cash ($2700 x 1/2) | 1350 | ||
(To record repayment of refundable deposits) |
Saved Help av Grossman Products began operations in 2021. The following selected transactions occurred from September...
Grossman Products began operations in 2021. The following selected transactions occurred from September 2021 through March 2022. Grossman's fiscal year ends on December 31. 2021: (a.) On September 5, Grossman opened a checking account and negotiated a short-term line of credit of up to $9,100,000 at 10% interest. The company is not required to pay any commitment fees. (b.) On October 1, Grossman borrowed $7,100,000 cash and issued a 5-month promissory note with 12% interest payable at maturity. (c.) Grossman...
Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $33,000,000 at the bank's prime rate (15.5% at the time). The company will pay no commitment fees. b. On October 1,...
Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2021 On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $20,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. On October 1, borrowed $17...
Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $20,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. b. On October 1,...
Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $20,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. b. On October 1,...
Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $16,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. b. On October 1,...
Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $23,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. b. On October 1,...
Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $31,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. b. On October 1,...
Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2021 On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $17,000,000 at the bank's prime rate (12.5% at the time). The company will pay no commitment fees. On October 1, borrowed $14...
Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $27,000,000 at the bank's prime rate (12.5% at the time). The company will pay no commitment fees. b. On October 1,...